Valbenazine
IRB25-0568
Phase 2 small_molecule active
Quick answer
Valbenazine for Obsessive-Compulsive Disorder is a Phase 2 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Obsessive-Compulsive Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active